Is European Biotech Acquisition Corp. (EBAC) a Buy, Sell, or Hold?
NASDAQ : EBAC
European Biotech Acquisition Corp. — Competitors
$11.19 USD
-$0.52 (-4.44%)
- Volume
- 77.64K
- Average Volume
- 129.82K
- Market Capitalization
- $183.5M
- P/E Ratio
- 41.44
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $14.10
- Year Low
- $9.28
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.45
EBAC vs. The Competition
| Properties | EBAC | APCA | BTWN | CONX |
|---|---|---|---|---|
| Market Cap | $183.5M | $178.79M | $184.3M | $3.43M |
| Shares Outstanding | $16.4M | $15.61M | $29.97M | $689.48K |
| P/E Ratio | 41.44 | 67.35 | 1.38 | |
| EPS | 0.27 | 0.17 | 3.59 | |
| Day Low | 10.55 | 11.45 | 6.02 | 4.96 |
| Day High | 11.6899 | 11.47 | 6.52 | 5.32 |
| Year Low | 9.282 | 10.78 | 5.38 | 4.34 |
| Year High | 14.1 | 12.415 | 10.43 | 28.336 |
| Average Price 50 | 10.1899 | 11.401616 | 9.918566 | 6.17306 |
| Average Price 200 | 9.965125 | 11.188676 | 10.067149 | 11.85183 |
| Volume | 77641 | 98401 | 159.23K | 71578 |
| Average Volume | - | - | - | - |